Hypophosphatemic Rickets: Lessons from Disrupted FGF23 Control of Phosphorus Homeostasis

Bracha K. Goldsweig, Thomas O. Carpenter

Research output: Contribution to journalReview article

25 Citations (Scopus)

Abstract

Fibroblast growth factor-23 (FGF23) regulates phosphate reabsorption in the kidney and therefore plays an essential role in phosphate balance in humans. There is a host of defects that ultimately lead to excess FGF23 levels and thereby cause renal phosphate wasting and hypophosphatemic rickets. We describe the genetic, pathophysiologic, and clinical aspects of this group of disorders with a focus on X-linked hypophosphatemia (XLH), the best characterized of these abnormalities. We also discuss autosomal dominant hypophosphatemic rickets (ADHR), autosomal recessive hypophosphatemic rickets (ARHR) and tumor-induced osteomalacia (TIO) in addition to other rarer FGF23-mediated conditions. We contrast the FGF23-mediated disorders with FGF23-independent hypophosphatemia, specifically hypophosphatemic rickets with hypercalciuria (HHRH). Errant diagnosis of hypophosphatemic disorders is common. This review aims to enhance the recognition and appropriate diagnosis of hypophosphatemia and to guide appropriate treatment.

Original languageEnglish (US)
Pages (from-to)88-97
Number of pages10
JournalCurrent Osteoporosis Reports
Volume13
Issue number2
DOIs
StatePublished - Jan 1 2015

Fingerprint

Hypophosphatemic Rickets
Phosphorus
Homeostasis
Hypophosphatemia
Phosphates
Familial Hypophosphatemic Rickets
Kidney
Hypercalciuria
fibroblast growth factor 23

Keywords

  • Bone
  • FGF23
  • Osteomalacia
  • Phosphate
  • Rickets

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Hypophosphatemic Rickets : Lessons from Disrupted FGF23 Control of Phosphorus Homeostasis. / Goldsweig, Bracha K.; Carpenter, Thomas O.

In: Current Osteoporosis Reports, Vol. 13, No. 2, 01.01.2015, p. 88-97.

Research output: Contribution to journalReview article

@article{8f43e54ffb1342f2930ff14d7965ae1d,
title = "Hypophosphatemic Rickets: Lessons from Disrupted FGF23 Control of Phosphorus Homeostasis",
abstract = "Fibroblast growth factor-23 (FGF23) regulates phosphate reabsorption in the kidney and therefore plays an essential role in phosphate balance in humans. There is a host of defects that ultimately lead to excess FGF23 levels and thereby cause renal phosphate wasting and hypophosphatemic rickets. We describe the genetic, pathophysiologic, and clinical aspects of this group of disorders with a focus on X-linked hypophosphatemia (XLH), the best characterized of these abnormalities. We also discuss autosomal dominant hypophosphatemic rickets (ADHR), autosomal recessive hypophosphatemic rickets (ARHR) and tumor-induced osteomalacia (TIO) in addition to other rarer FGF23-mediated conditions. We contrast the FGF23-mediated disorders with FGF23-independent hypophosphatemia, specifically hypophosphatemic rickets with hypercalciuria (HHRH). Errant diagnosis of hypophosphatemic disorders is common. This review aims to enhance the recognition and appropriate diagnosis of hypophosphatemia and to guide appropriate treatment.",
keywords = "Bone, FGF23, Osteomalacia, Phosphate, Rickets",
author = "Goldsweig, {Bracha K.} and Carpenter, {Thomas O.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/s11914-015-0259-y",
language = "English (US)",
volume = "13",
pages = "88--97",
journal = "Current Osteoporosis Reports",
issn = "1544-1873",
publisher = "Current Science, Inc.",
number = "2",

}

TY - JOUR

T1 - Hypophosphatemic Rickets

T2 - Lessons from Disrupted FGF23 Control of Phosphorus Homeostasis

AU - Goldsweig, Bracha K.

AU - Carpenter, Thomas O.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Fibroblast growth factor-23 (FGF23) regulates phosphate reabsorption in the kidney and therefore plays an essential role in phosphate balance in humans. There is a host of defects that ultimately lead to excess FGF23 levels and thereby cause renal phosphate wasting and hypophosphatemic rickets. We describe the genetic, pathophysiologic, and clinical aspects of this group of disorders with a focus on X-linked hypophosphatemia (XLH), the best characterized of these abnormalities. We also discuss autosomal dominant hypophosphatemic rickets (ADHR), autosomal recessive hypophosphatemic rickets (ARHR) and tumor-induced osteomalacia (TIO) in addition to other rarer FGF23-mediated conditions. We contrast the FGF23-mediated disorders with FGF23-independent hypophosphatemia, specifically hypophosphatemic rickets with hypercalciuria (HHRH). Errant diagnosis of hypophosphatemic disorders is common. This review aims to enhance the recognition and appropriate diagnosis of hypophosphatemia and to guide appropriate treatment.

AB - Fibroblast growth factor-23 (FGF23) regulates phosphate reabsorption in the kidney and therefore plays an essential role in phosphate balance in humans. There is a host of defects that ultimately lead to excess FGF23 levels and thereby cause renal phosphate wasting and hypophosphatemic rickets. We describe the genetic, pathophysiologic, and clinical aspects of this group of disorders with a focus on X-linked hypophosphatemia (XLH), the best characterized of these abnormalities. We also discuss autosomal dominant hypophosphatemic rickets (ADHR), autosomal recessive hypophosphatemic rickets (ARHR) and tumor-induced osteomalacia (TIO) in addition to other rarer FGF23-mediated conditions. We contrast the FGF23-mediated disorders with FGF23-independent hypophosphatemia, specifically hypophosphatemic rickets with hypercalciuria (HHRH). Errant diagnosis of hypophosphatemic disorders is common. This review aims to enhance the recognition and appropriate diagnosis of hypophosphatemia and to guide appropriate treatment.

KW - Bone

KW - FGF23

KW - Osteomalacia

KW - Phosphate

KW - Rickets

UR - http://www.scopus.com/inward/record.url?scp=84925535455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925535455&partnerID=8YFLogxK

U2 - 10.1007/s11914-015-0259-y

DO - 10.1007/s11914-015-0259-y

M3 - Review article

C2 - 25620749

AN - SCOPUS:84925535455

VL - 13

SP - 88

EP - 97

JO - Current Osteoporosis Reports

JF - Current Osteoporosis Reports

SN - 1544-1873

IS - 2

ER -